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Abstract Transfection is a powerful analytical tool en-
abling study of the function of genes and gene products in
cells. The transfection methods are broadly classified into
three groups; biological, chemical, and physical. These
methods have advanced to make it possible to deliver
nucleic acids to specific subcellular regions of cells by use
of a precisely controlled laser-microcope system. The
combination of point-directed transfection and mRNA
transfection is a new way of studying the function of genes
and gene products. However, each method has its own
advantages and disadvantages so the optimum method
depends on experimental design and objective.
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Introduction
Transfection is a procedure that introduces foreign nucleic
acids into cells to produce genetically modified cells.
Transfection is a powerful analytical tool for study of gene
function and regulation and protein function. The intro-
duced genetic materials (DNAs and RNAs) exist in cells
either stably or transiently depending on the nature of the
genetic materials [1]. For stable transfection, introduced
genetic materials that usually have a marker gene for
selection (transgenes) are integrated into the host genome
and sustain transgene expression even after host cells
replicate (Fig. 1a)[ 2]. In contrast with stably transfected
genes, transiently transfected genes are only expressed for a
limited period of time and are not integrated into the
genome (Fig. 1b)[ 1]. Transiently transfected genetic
materials can be lost by environmental factors and cell
division, so the choice of stable or transient transfection
depends on the objective of the experiment. The main
purpose of transfection is to study the function of genes or
gene products, by enhancing or inhibiting specific gene
expression in cells, and to produce recombinant proteins in
mammalian cells [3]. Examples are: gene therapy delivering
a gene of interest into cells to cure a disease or improve
symptoms; induced pluripotent stem cell (iPS cell) gener-
ation by transfecting three or four transcription factors;
small interference RNA (siRNA) knock-down procedures;
and production of human tissue plasminogen activator in
immortalized Chinese hamster ovary (CHO) cells for
therapeutic purpose [3–6].
Methodological diversity
Many transfection methods have been developed (Table 1).
Each method uses different approaches that must be
considered depending on cell type and purpose. The ideal
method should have high transfection efficiency, low cell
toxicity, minimal effects on normal physiology, and be easy
to use and reproducible.
For this discussion, the methods are broadly classified
into biologically, chemically, and physically mediated
methods.
T. K. Kim: J. H. Eberwine
Department of Pharmacology,
University of Pennsylvania Medical School—Pharmacology,
36th and Hamilton Walk,
Philadelphia, PA 19104, USA
J. H. Eberwine (*)
Penn Genome Frontiers Institute,
University of Pennsylvania Medical School—Pharmacology,
36th and Hamilton Walk,
Philadelphia, PA 19104, USA
e-mail: eberwine@upenn.edu
Anal Bioanal Chem (2010) 397:3173–3178
DOI 10.1007/s00216-010-3821-6Biological methods
The most commonly used method in clinical research is
virus-mediated transfection, also known as transduction [4].
Virus-mediated transfection is highly efficient and it is easy
to achieve sustainable transgene expression in vivo owing
to the viral nature of integration into the host genome. For
example, retrovirus murine leukemia virus (MLV) has been
used as a viral vector to establish sustainable transgene
expression in humans [7, 8]. MLV integrates its DNA into
the host genome and the integrated DNA is expressed in the
host. The integrated MLV DNA replicates as the host
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two different transfections. (a)
Stable transfection. Foreign
DNA (red wave) is delivered to
nucleus by passage through the
cell and nuclear membranes.
Foreign DNA is integrated into
the host genome (black wave)
and expressed sustainably. (b).
Transient transfection. Foreign
DNA is delivered into the
nucleus but is not integrated into
the genome. Foreign mRNA
(blue wave) is also delivered
into the cytosol, where it is
translated. Hexagons are
expressed proteins from
transfected nucleic acids. Black
arrows indicate delivery of
foreign nucleic acids
Table 1 Conventional transfection methods
Class Methods Advantages Disadvantages Examples Refs.
Biological ● Virus-mediated - High-efficiency - Potential hazard to
laboratory personnel
Herpes simplex virus, Adeno
virus, Adeno-associated virus,
[4, 7–9]
- Easy to use Vaccinia virus, Sindbis virus
- Effective on dissociated
cells, slices, and in vivo
- Insertional mutagenesis
- Immunogenicity
- DNA package size limit
Chemical ● Cationic polymer - No viral vector - Chemical toxicity to some
cell types
DEAE-dextran, polyethyleneimine,
dendrimer, polybrene, calcium
phosphate, lipofectin, DOTAP,
lipofectamine, CTAB/DOPE,
DOTMA
[10–12]
● Calcium phosphate - High-efficiency - Variable transfection
efficiency by cell type
or condition
● Cationic lipid - Easy to use - Hard to target specific cells
- Effective on dissociated
cells and slices
- Plenty of commercially
available products
- No package size limit
Physical ● Direct injection - Simple principle and
straightforward
- Needs special instruments Micro-needle, AFM tip, Gene
Gun, Amaxa Nucleofector,
phototransfection, Magnetofection
[13–25]
● Biolistic particle
delivery
- Physical relocation of
nucleic acids into cell
- Vulnerable nucleic acids
● Electroporation - No need for vector - Demands experimenter skill,
laborious procedure
● Laser-irradiation - Less dependent on cell type
and condition
● Sonoporation - Single-cell transfection
● Magnetic
nanoparticle
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cells, which enables sustainable transgene expression.
The major drawbacks of virus-mediated transfection are
immunogenicity and cytotoxicity. Introduction of a viral
vector may cause an inflammatory reaction and an
insertional mutation, because viral vectors integrate into
the host genome randomly, which may disrupt tumor
suppressor genes, activate oncogenes, or interrupt essential
genes [9]. Another disadvantage of this method is that a
virus package has limited space for a foreign gene to keep
infectivity. For these reasons, much effort has been made to
develop non-viral transfection methods even though virus-
mediated transfection is highly effective and easy to use.
Chemical methods
Chemical transfection methods are the most widely used
methods in contemporary research and were the first to be
used to introduce foreign genes into mammalian cells [10].
Chemical methods commonly use cationic polymer (one of
the oldest chemicals used), calcium phosphate, cationic
lipid (the most popular method), and cationic amino acid
[10–12]. The underlying principle of chemical methods is
similar. Positively charged chemicals make nucleic acid/
chemical complexes with negatively charged nucleic acids.
These positively charged nucleic acid/chemical complexes
are attracted to the negatively charged cell membrane. The
exact mechanism of how nucleic acid/chemical complexes
pass through the cell membrane is unknown but it is
believed that endocytosis and phagocytosis are involved in
the process. Transfected DNA must be delivered to the
nucleus to be expressed and again the translocation
mechanism to the nucleus is not known.
The transfection efficiency of chemical methods is
largely dependent on factors such as nucleic acid/chemical
ratio, solution pH, and cell membrane conditions, so the
process results in low transfection efficiency, especially in
vivo, compared with virus-mediated methods. However,
these methods have merits of relatively low cytotoxicity, no
mutagenesis, no extra-carrying DNA, and no size limitation
on the packaged nucleic acid. Chemical transfection
efficiency also varies depending on cell type.
Physical methods
The physical transfection methods are the most recent
methods and use diverse physical tools to deliver nucleic
acids. The methods include direct micro injection, biolistic
particle delivery, electroporation, and laser-based transfection
[13]. In brief, the micro injection method directly injects
nucleic acid into the cytoplasm or nucleus [14, 15]. This
method delivers nucleic acids into cells but demands skill,
often causes cell death, and is very labor-intensive. Biolistic
particle delivery employs gold particles that conjugate with
nucleic acids [16, 17]. The nucleic acid/particle conjugates
are then shot into recipient cells at a high velocity (“gene
gun”). This method is straightforward and reliable but it
requires expensive instruments and causes physical damage
to samples. Electroporation is the most widely used physical
method. The exact mechanism is unknown but it is supposed
that a short electrical pulse disturbs cell membranes and
makes holes in the membrane through which nucleic acids
can pass [18]. Because electroporation is easy and rapid, it
is able to transfect a large number of cells in a short time
once optimum electroporation conditions are determined.
Laser-mediated transfection (also known as optoporation
or phototransfection) uses a pulse laser to irradiate a cell
membrane to form a transient pore [19–22]. When the
laser induces a pore in the membrane, nucleic acids in the
medium are transferred into the cell because of the osmotic
difference between the medium and the cytosol. The laser
method enables one to observe the transfecting cell and to
make pores at any location on the cell. This method can be
applied to very small cells, because it uses a laser, but it
requires an expensive laser-microscope system. In addition
to those mentioned above, there are other physical
methods using ultrasound (sonoporation) and magnetic
field (magnetofection) [23–25].
Transfection of RNAs
Transfecting mRNA has several merits over DNA transfection
[26]. The merits include no risk of integration into the host
genome, cell cycle-independent transfection efficiency, no
need for immune inducible vectors, and adjustable and rapid
expression. Using mRNA transfection, one can introduce any
number of mRNAs into a cell, thereby overcoming over-
expression of the genes. These advantages mostly originate
from the fact that mRNA does not need to be located in a
nucleus to be expressed. Transfected DNA must carry a host
cell or tissue-specific promoter to be transcribed to mRNA
and the expression level is determined by strength of the
promoter. In contrast with DNA transfection, one can adjust
expression levels by changing the amount of mRNA trans-
fected and the frequency of transfection in mRNA transfec-
tion. Other strong advantages of mRNA transfection are:
1. transfected mRNAs can be expressed within minutes
after transfection because it skips translocation to the
nucleus and transcription process; and
2. transcriptome (population of mRNAs) can be used for
transfection, which is practically difficult in DNA
transfection (Fig. 2)[ 20, 27, 28].
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for therapeutic purposes [29]. However, we have to
acknowledge that matured mRNA consists of five signifi-
cant structures (the cap, 5′ untranslated region (5′UTR),
open reading frame (ORF), 3′ untranslated region (3′UTR),
and poly-A tail) and undergoes nucleoside modifications,
which are important to the translation of the mRNA [30,
31]. Therefore the plasmid used for in-vitro transcription
must be designed with consideration of all factors affecting
stability and translational efficiency. Handling mRNA
demands more caution but mRNA transfection encourages
alternation with DNA transfection for many applications.
RNA interference (RNAi) is a powerful tool to knock-
down specific genes and to observe consequent changes of
phenotypes [6, 32]. Introduced small inhibitory RNAs
(siRNA) form RNA-induced silencing complex (RISC) in
Fig. 2 Micrographs of the rat
hippocampal neuron lipotrans-
fected with in-vitro-transcribed
rat Gria4-GFP mRNA. (a) DIC
image. (b) Fluorescence image
before transfection. c, d, e, and
f. Fluorescence images 2, 4, 6,
and 8 h, respectively, after
transfection. Note the
time-dependant increases
in fluorescence
Fig. 3 An illustration of phototransfection. Laser beams (green flashes)
create holes at specific regions of single cell (subcellular locations) and
nucleic acids (red dots) are delivered into the local areas
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expression. The most common methods used to deliver
siRNA are lipid/polymer-mediated delivery and virus-
mediated delivery. Despite the wide use of siRNA, large
efforts are still being made to develop more effective, safe,
and reliable methods to deliver siRNAs into cells, because
of the great potential of RNAi in clinical use to treat
diseases [33]. Both relatively new transfection methods,
mRNA and siRNA transfection, lead to new ways to
execute cell research with their own distinctive advantages.
Single-cell transfection
Each cell has distinct gene-expression patterns even when
sharing morphological similarities. Because the functions of
a cell are determined by its location and time, single-cell
resolution of gene expression is important to elucidate gene
function. To achieve single-cell resolution of gene function,
reliable single-cell transfection methods are needed. Some
physical transfection methods have been applied to single-
cell transfection with good results. Examples are:
1. micro-injections using a very small glass needle, nano-
needle, femtosyringe. and atomic-force microscopy
(AFM) tips [34–37];
2. electroporation using a micropipette filled with nucleic
acids and an electric field [38]; and
3. phototransfection using a multi-photon laser [20].
All methods are performed under a microscope so that
transfected cells can be trailed in real time. Micro-injection is
straightforward and efficient but all the types of injectors
actually perforate cell membranes resulting in physical
damage to the cells. Single-cell electroporation efficiently
delivers nucleic acids into single cells and can easily be
applied in vivo. Single-cell electroporation of enhanced
green fluorescence protein (EGFP) plasmid has shown the
morphology and growth characteristics of a single neuron in
vivo [38]. Phototransfection is the most accurate means of
delivering nucleic acids (Fig. 3). Because the numbers and
sizes of holes on the cell membrane can be adjusted, this
method is the most suitable way of delivering population
mRNAs. The additional advantage of phototransfection is
that we can dictate subcellular location through which
nucleic acids pass (e.g. axon or dendrite on neuron), which
is not possible by electroporation. Introducing nucleic acids
into a subcellular location is important for study of single
polarized cells in which different cellular domains perform
distinct activities. Neurons, especially, have soma, den-
drites, and axons, each with a different function and
localized gene expression. For example, transfection of E-
26-like protein 1 (Elk-1) mRNA into dendrites of intact
primary rat neurons induced cell death but introduction of
Elk-1 mRNA in cell body did not cause cell death [20].
This experiment proved that localization of specific mRNA
significantly altered the function of the mRNA, which was
impossible to do using traditional transfection methods. The
experiment could not be performed without a combination
of mRNA transfection and subcellular locational transfec-
tion. Therefore, the combination of mRNA transfection and
phototransfection is a powerful tool for study of gene
function in single cells by virtue of point-directed delivery
and immediate action of mRNA.
Outlook
Transfection methods are evolving rapidly. Even within a
class, many new products and technologies are launched
each year with improved efficiency and less cytotoxicity.
From the virus-mediated method to laser-mediated method,
each method has its own advantages and disadvantages so
selection of the best method depends upon the experimenter’s
experimental objectives.
Future transfection technology should expand in two
directions, being precise enough to transfect subcellular
regions and up to whole-individual transfection. The ability
to deliver foreign nucleic acids (especially mRNA) into
subcellular locations (e.g. axon or dendrite) and organelles
(e.g. mitochondria, golgi apparatus, or nucleus) will open
an new era for genetic research because it will change how
we think about and assess the function of genes in a cell. In
addition to the overall gene expression profiles of a cell, the
location of expressed gene products plays a crucial role in
determining the function of a cell [20]. Meanwhile, safe and
reliable transfection methods that can be applicable to
humans are needed to establish clinical therapeutics.
In summary, transfection methodology has developed
rapidly and diversely. Consequently we now have plenty of
options to choose from, fitting well into our experimental or
clinical needs. However, as cell research progresses, more
advanced transfection technologies are still in demand.
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